Literature DB >> 1736847

Protein redistribution diet remains effective in patients with fluctuating parkinsonism.

P J Karstaedt1, J H Pincus.   

Abstract

Forty-three carbidopa-levodopa (Sinemet)-treated parkinsonian patients with protein-sensitive motor fluctuations were started on the protein redistribution diet within the past 48 months. Thirty patients (70%) are still using the diet successfully after more than 12 months (mean duration, 33.6 months; range, 12 to 48 months). The diet was discontinued in the other 13 cases. In 10 of these 13 patients, the protein redistribution diet was discontinued for a variety of reasons, despite continued sensitivity to dietary protein; in only three patients (7%), those with the most severe and complicated disease, was the protein redistribution diet stopped because of its limited therapeutic benefit. The protein redistribution diet is a simple adjunct to the treatment of Parkinson's disease that can significantly prolong the efficacy of levodopa therapy in many fluctuating "end-stage" patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736847     DOI: 10.1001/archneur.1992.00530260049018

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

Review 1.  Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.

Authors:  Dirk Deleu; Margaret G Northway; Yolande Hanssens
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Nutritional therapies in Parkinson's disease.

Authors:  Marian L Evatt
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

3.  Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson's disease.

Authors:  Tuhin Virmani; Sirinan Tazan; Pietro Mazzoni; Blair Ford; Paul E Greene
Journal:  J Clin Mov Disord       Date:  2016-05-26

Review 4.  Protein-Restricted Diets for Ameliorating Motor Fluctuations in Parkinson's Disease.

Authors:  Luxi Wang; Nian Xiong; Jinsha Huang; Shiyi Guo; Ling Liu; Chao Han; Guoxin Zhang; Haiyang Jiang; Kai Ma; Yun Xia; Xiaoyun Xu; Jie Li; Jing Y Liu; Tao Wang
Journal:  Front Aging Neurosci       Date:  2017-06-28       Impact factor: 5.750

Review 5.  Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

Authors:  Dag Nyholm
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 5.577

6.  Dietary Approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson's Disease: A Systematic Review.

Authors:  Jikke T Boelens Keun; Ilse Ac Arnoldussen; Chris Vriend; Ondine van de Rest
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 8.701

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.